No Difference Observed Between Branded, Biosimilar Enoxaparin for Post-Operative Thrombosis

There was no statistically significant difference between Lovenox (Sanofi–Aventis Pharmaceuticals, France) and biosimilar enoxaparin in the occurrence of post-operative thrombosis for digestive cancer.

Related Keywords

Tunisia ,Mmedis ,Poitou Charentes ,France , ,Aventis Pharmaceuticals ,Amedis Pharmaceuticals ,